FLAM
First Light Asset Management Portfolio holdings
AUM
$771M
This Quarter Return
-17%
1 Year Return
+33.17%
3 Year Return
+208.13%
5 Year Return
+426.73%
10 Year Return
+3,318.8%
AUM
$1.05B
AUM Growth
+$1.05B
(-17%)
Cap. Flow
+$12.7M
Cap. Flow
% of AUM
1.2%
Top 10 Holdings %
Top 10 Hldgs %
48.18%
Holding
82
New
3
Increased
31
Reduced
12
Closed
7
Top Buys
| 1 |
Pliant Therapeutics
PLRX
|
$19.5M |
| 2 |
Tactile Systems Technology
TCMD
|
$19.1M |
| 3 |
Ultragenyx Pharmaceutical
RARE
|
$19.1M |
| 4 |
Structure Therapeutics
GPCR
|
$18.9M |
| 5 |
Tandem Diabetes Care
TNDM
|
$17.5M |
Top Sells
| 1 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
$146M |
| 2 |
ABCM
Abcam plc American Depositary Shares
ABCM
|
$17.4M |
| 3 |
Krystal Biotech
KRYS
|
$11.9M |
| 4 |
Halozyme
HALO
|
$10.3M |
| 5 |
Orthofix Medical
OFIX
|
$7.8M |
Sector Composition
| 1 | Healthcare | 95.63% |
| 2 | Communication Services | 4.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Exelixis
EXEL
$9.95B
| $403K | 0.04% |
18,445
| – | – |
|
52
Takeda Pharmaceutical
TAK
$47.8B
| $396K | 0.04% |
25,630
| – | – |
|
53
Elevance Health
ELV
$72.4B
| $386K | 0.04% |
886
| – | – |
|
54
Centene
CNC
$14.8B
| $380K | 0.04% |
5,521
| – | – |
|
55
Enovis
ENOV
$1.75B
| $380K | 0.04% |
7,203
| – | – |
|
56
AbbVie
ABBV
$374B
| $379K | 0.04% |
+2,540
| New | +$379K |
|
57
Smith & Nephew
SNN
$16.2B
| $374K | 0.04% |
15,111
| – | – |
|
58
GSK
GSK
$79.3B
| $365K | 0.03% |
10,058
| – | – |
|
59
Gilead Sciences
GILD
$140B
| $339K | 0.03% |
4,526
| – | – |
|
60
Johnson & Johnson
JNJ
$429B
| $337K | 0.03% |
2,161
| – | – |
|
61
Medtronic
MDT
$118B
| $328K | 0.03% |
4,188
| – | – |
|
62
Viatris
VTRS
$12.3B
| $325K | 0.03% |
33,010
| – | – |
|
63
QuidelOrtho
QDEL
$1.87B
| $311K | 0.03% |
4,257
| – | – |
|
64
Avantor
AVTR
$8.74B
| $308K | 0.03% |
14,596
| – | – |
|
|
BAY
65
DELISTED
BAYER AG SPONS ADR
BAY
| $306K | 0.03% |
25,475
| – | – |
|
66
United Therapeutics
UTHR
$17.7B
| $304K | 0.03% |
1,345
| – | – |
|
67
HCA Healthcare
HCA
$95.4B
| $285K | 0.03% |
1,160
| – | – |
|
68
Biogen
BIIB
$20.8B
| $282K | 0.03% |
1,096
| – | – |
|
69
Dentsply Sirona
XRAY
$2.77B
| $281K | 0.03% |
8,228
| – | – |
|
70
Qiagen
QGEN
$10.1B
| $280K | 0.03% |
6,912
| – | – |
|
71
Integra LifeSciences
IART
$1.18B
| $277K | 0.03% |
7,261
| – | – |
|
|
PDCO
72
DELISTED
Patterson Companies, Inc.
PDCO
| $275K | 0.03% |
9,264
| – | – |
|
73
Revvity
RVTY
$9.68B
| $246K | 0.02% |
2,223
| – | – |
|
74
Labcorp
LH
$22.8B
| $245K | 0.02% |
1,218
| – | -$40.2K |
|
75
Organon & Co
OGN
$2.56B
| $221K | 0.02% |
12,716
| – | – |
|